YAP Mediates EGFR Inhibitor-Induced Dormancy in EGFR-Mutant Cancer
- PMID: 31980569
- DOI: 10.1158/2159-8290.CD-RW2020-013
YAP Mediates EGFR Inhibitor-Induced Dormancy in EGFR-Mutant Cancer
Abstract
YAP activation mediates resistance to EGFR and MEK inhibition in EGFR-mutant cancer cells.
©2020 American Association for Cancer Research.
Comment on
-
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.Cancer Cell. 2020 Jan 13;37(1):104-122.e12. doi: 10.1016/j.ccell.2019.12.006. Cancer Cell. 2020. PMID: 31935369 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous